Sanaa Sayagh of Roche Morocco shares her commitment to bringing the latest immunotherapies to Moroccan patients through partnerships with health authorities and the Lalla Salma Foundation on creative access programs. Sayagh also touches on how Roche is attempting to make personalised healthcare a reality in Morocco.
Despite the lack of visibility on approval timelines, we are already running clinical trials locally, because we are convinced about the high value clinical trials can bring to the healthcare system in our country
